Pseudo-Pseudo Meigs' Syndrome-Like Presentation Associated with Primary Sjögren's Syndrome: A Case Report. [PDF]
Xun J +6 more
europepmc +1 more source
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec +6 more
wiley +1 more source
Quantifying molecular specificity in excipient-driven antibody solubilization. [PDF]
Han Z +7 more
europepmc +1 more source
CLDN18.2 antibody design with protein language models: A deep learning optimization framework. [PDF]
Qu T +8 more
europepmc +1 more source
Antibody-Dependent Enhancement in Flavivirus Infections: From Fc Receptor Signaling to Vaccine and Therapeutic Design. [PDF]
Li Y, Wu Z, Cha Y, Pang W, Sun L.
europepmc +1 more source
Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study. [PDF]
Huang Y +7 more
europepmc +1 more source
From Payload-First Toward Dual-Mechanism Antibody-Drug Conjugates. [PDF]
Pivot X, Jung S, Harlepp S, Detappe A.
europepmc +1 more source
[Corrigendum] Coenzyme Q10 alleviates sevoflurane‑induced neuroinflammation by regulating the levels of apolipoprotein E and phosphorylated tau protein in mouse hippocampal neurons. [PDF]
Yang M +5 more
europepmc +1 more source
Related searches:
Antibody and antibody fragments for cancer immunotherapy
Journal of Controlled Release, 2020Antibody has become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases including cancers. Especially, with the fast development of cancer immunotherapy, antibody drugs have become the most promising therapeutic for curing cancers.
Xiqun Jiang, Weizhi Chen
exaly +3 more sources

